Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.
about
Cell-mediated immunity and its role in resistance to infection.Human lymphoblastoid interferon in the treatment of small cell lung cancer.Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas.Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.The failure of human leukocyte interferon to influence the growth of human glioma cell populations: in vitro and in vivo studiesHuman fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.Antiviral therapy.Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.Interferons: anti-neoplastic drugs?Inhibition of Herpesvirus hominis replication by human interferon.Epstein-Barr herpesvirus infection: inhibition by immunologically induced mediators with interferon-like properties.Interferon therapy: pharmacokinetic and pharmacological aspects.The human interferon system.Interferon--present and future prospects.The human interferons.Treatment of herpes zoster. Recombinant alpha interferon versus acyclovir.Pharmacologic effects of polyinosinic-polycytidylic acid in man.Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.Electron microscopic observations on the lesions of herpes zoster with topical application of interferon.Human leukocyte interferon administration to patients with symptomatic and suspected rabies.Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.
P2860
Q30447984-24243F24-D3AC-49A2-BE22-7D2D2F63A3C9Q33476926-DD3BF221-196A-471E-9ACD-2E211312F5B2Q34091411-AE149F25-127A-434B-BA09-7CE496ECFAADQ34123702-B75017F2-D8FF-4927-8DD2-9746A80076DEQ35896986-7D69EAA2-C6B0-4710-89A8-0F15A0AE8C1AQ36048399-3EB48D99-76FB-41F9-AFF8-2C2E139DE02EQ36481620-FE7B0898-E796-456A-AE75-594DDB455686Q36998696-B8BFE31A-4AD2-440F-BCFF-C529B0BD9FD0Q37322314-6F1F1C60-C793-4571-B79C-A1031072308AQ39707996-96CCF9F1-7E70-4429-8596-C57DC61FB954Q39937247-EE7F95B0-0288-47F3-91AB-4C06D38A0A0BQ40099412-36E008B3-9C76-4FD8-AC47-F008D72F9519Q40099867-22B2189F-F597-4E5F-9A1E-FA85C1B61A25Q40102632-25CC7C5B-BC0E-4162-9CD4-068021ED77FBQ40109995-6AD1EEB8-CC4D-4D5B-B102-E201E91AB833Q40249324-28C662B3-766C-48B9-907F-E722835CAAF5Q40787296-FEF88C30-A246-42B8-AFA4-883A79EEB808Q40880824-27412CDD-8776-4BB3-87DF-34593F628A27Q41865084-9B456149-0A2F-4742-9524-5989A9F1CE11Q47969823-8E531AA1-0927-4F9B-B926-4F2E25BC4DF0Q48653620-A197D734-3E89-4A3A-BFCC-9A3CD9083EBFQ54563614-FD946FFA-026B-49CF-9B4C-CBBA75B19F1F
P2860
Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Administration of human leukoc ...... d host responses to infection.
@en
type
label
Administration of human leukoc ...... d host responses to infection.
@en
prefLabel
Administration of human leukoc ...... d host responses to infection.
@en
P2093
P356
P1476
Administration of human leukoc ...... d host responses to infection.
@en
P2093
P356
10.1093/INFDIS/130.1.56
P407
P577
1974-07-01T00:00:00Z